Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

NCT06479720 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Effect of Drug
Urinary Bladder, Overactive

Interventions

DRUG: Combined pharmacotherapy with Solifenacin and Mirabegron
DRUG: Solifenacin with vaginal estrogen cream
DRUG: Mirabegron with vaginal estrogen cream

Sponsor

Mackay Memorial Hospital